These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 20643512)

  • 1. Adaptive dose painting by numbers for head-and-neck cancer.
    Duprez F; De Neve W; De Gersem W; Coghe M; Madani I
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1045-55. PubMed ID: 20643512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensity modulated arc therapy implementation in a three phase adaptive (18)F-FDG-PET voxel intensity-based planning strategy for head-and-neck cancer.
    Berwouts D; Olteanu LA; Speleers B; Duprez F; Madani I; Vercauteren T; De Neve W; De Gersem W
    Radiat Oncol; 2016 Apr; 11():52. PubMed ID: 27039294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-phase adaptive dose-painting-by-numbers for head-and-neck cancer: initial results of the phase I clinical trial.
    Berwouts D; Olteanu LA; Duprez F; Vercauteren T; De Gersem W; De Neve W; Van de Wiele C; Madani I
    Radiother Oncol; 2013 Jun; 107(3):310-6. PubMed ID: 23647760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer.
    Madani I; Duthoy W; Derie C; De Gersem W; Boterberg T; Saerens M; Jacobs F; Grégoire V; Lonneux M; Vakaet L; Vanderstraeten B; Bauters W; Bonte K; Thierens H; De Neve W
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):126-35. PubMed ID: 17448871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of
    Berwouts D; Madani I; Duprez F; Olteanu AL; Vercauteren T; Boterberg T; Deron P; Bonte K; Huvenne W; De Neve W; Goethals I
    Head Neck; 2017 Nov; 39(11):2264-2275. PubMed ID: 28833829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of deformable image coregistration in adaptive dose painting by numbers for head-and-neck cancer.
    Olteanu LA; Madani I; De Neve W; Vercauteren T; De Gersem W
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):696-703. PubMed ID: 22153223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study.
    Lee NY; Mechalakos JG; Nehmeh S; Lin Z; Squire OD; Cai S; Chan K; Zanzonico PB; Greco C; Ling CC; Humm JL; Schöder H
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):2-13. PubMed ID: 17869020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [18FDG] PET-CT-based intensity-modulated radiotherapy treatment planning of head and neck cancer.
    El-Bassiouni M; Ciernik IF; Davis JB; El-Attar I; Reiner B; Burger C; Goerres GW; Studer GM
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):286-93. PubMed ID: 17707283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging.
    Scarfone C; Lavely WC; Cmelak AJ; Delbeke D; Martin WH; Billheimer D; Hallahan DE
    J Nucl Med; 2004 Apr; 45(4):543-52. PubMed ID: 15073248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maximum tolerated dose in a phase I trial on adaptive dose painting by numbers for head and neck cancer.
    Madani I; Duprez F; Boterberg T; Van de Wiele C; Bonte K; Deron P; De Gersem W; Coghe M; De Neve W
    Radiother Oncol; 2011 Dec; 101(3):351-5. PubMed ID: 21742392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia dose painting by numbers: a planning study.
    Thorwarth D; Eschmann SM; Paulsen F; Alber M
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):291-300. PubMed ID: 17448882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease Control and Late Toxicity in Adaptive Dose Painting by Numbers Versus Nonadaptive Radiation Therapy for Head and Neck Cancer: A Randomized Controlled Phase 2 Trial.
    De Bruycker A; De Neve W; Daisne JF; Vercauteren T; De Gersem W; Olteanu L; Berwouts D; Deheneffe S; Madani I; Goethals I; Duprez F
    Int J Radiat Oncol Biol Phys; 2024 Oct; 120(2):516-527. PubMed ID: 38387811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and robustness of dose painting by numbers in proton therapy with contour-driven plan optimization.
    Barragán AM; Differding S; Janssens G; Lee JA; Sterpin E
    Med Phys; 2015 Apr; 42(4):2006-17. PubMed ID: 25832091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Planning study for available dose of hypoxic tumor volume using fluorine-18-labeled fluoromisonidazole positron emission tomography for treatment of the head and neck cancer.
    Choi W; Lee SW; Park SH; Ryu JS; Oh SJ; Im KC; Choi EK; Kim JH; Jung SH; Kim S; Ahn SD
    Radiother Oncol; 2010 Nov; 97(2):176-82. PubMed ID: 20855118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodology for adaptive and robust FDG-PET escalated dose painting by numbers in head and neck tumors.
    Differding S; Sterpin E; Janssens G; Hanin FX; Lee JA; Grégoire V
    Acta Oncol; 2016; 55(2):217-25. PubMed ID: 26079436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer.
    Vanderstraeten B; Duthoy W; De Gersem W; De Neve W; Thierens H
    Radiother Oncol; 2006 Jun; 79(3):249-58. PubMed ID: 16564588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative dosimetry of three-phase adaptive and non-adaptive dose-painting IMRT for head-and-neck cancer.
    Olteanu LA; Berwouts D; Madani I; De Gersem W; Vercauteren T; Duprez F; De Neve W
    Radiother Oncol; 2014 Jun; 111(3):348-53. PubMed ID: 24746575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation.
    Schwartz DL; Ford EC; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellen B; Mattes D; Kinahan P; Meyer J; Phillips M; Leblanc M; Krohn K; Eary J; Laramore GE
    Head Neck; 2005 Jun; 27(6):478-87. PubMed ID: 15772953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma.
    Wang D; Schultz CJ; Jursinic PA; Bialkowski M; Zhu XR; Brown WD; Rand SD; Michel MA; Campbell BH; Wong S; Li XA; Wilson JF
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):143-51. PubMed ID: 16618577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Target volume delineation for head and neck cancer intensity-modulated radiotherapy].
    Lapeyre M; Toledano I; Bourry N; Bailly C; Cachin F
    Cancer Radiother; 2011 Oct; 15(6-7):466-72. PubMed ID: 21880533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.